Suranjan-A potent antiarthritic drug of unani medicine for geriatric population

Author:

Zaidi Zehra1,Nazir Shehla,Bano Uzma,Nasir Abdul,Jabeen Farkhunda

Affiliation:

1. , Jamia Hamdard, New Delhi, India

Abstract

Osteoarthritis is the most common form of arthritis among older adults. It is also one of the most common causes of physical disability among adults. Osteoarthritis (OA) is a long-term chronic disease characterized by the deterioration of the cartilage in joints which results in bones rubbing together and creating stiffness, pain, and impaired movement. The pharmaco therapy can be associated with serious side effects and high costs. Now a day’s herbal medications have shown the potential for safe and effective management of arthritis and Unani medicine can provide an alternate therapy for Osteoarthritis. Suranjan Shireen-out of several herbal drugs in Unani Medicine is a potent and safe antiarthritic drug this has been proved in many in-vivo and in-vitro studies. Suranjan Shireen is effective against Arthralgia, Rheumatoid Arthritis and Gout. I have summarised the various clinical studies in this article to prove the therapeutic potentials of the Suranjan-shireen and Talkh with its Unani aspect to help the future scientist to explore this drug through clinical trial for treatment of various forms of OA specially in growing old age population.

Publisher

IP Innovative Publication Pvt Ltd

Subject

General Engineering

Reference23 articles.

1. Ansari , Colchicum luteum Baker (Suranjan Talkh): Current Perspective on Therapeutic Properties.Asian J Trad Com Alt Med 2020;3(1-2):23-8

2. Suhail S, Phytochemical and Pharmacological Review of Suranjan Shireen (Colchicum utumnale). (Colchicum autumnale). Indo Am J Pharm Res 2017;7(4):8492-6

3. Kolasinski , ACR/AF Guideline for Management of Hand, hip, and knee OA..Arthritis Care Res 2020;72(2):149-62

4. Hakeem M, .Bustan-ul-Mufredat.207

5. Ghani N, Advia K, .Tarjuman-ul-Tib.916-7

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3